Modine Manufacturing Company vs UnitedHealth Group Inc — how do they compare? Modine Manufacturing Company trades at $184.5 (market cap $10.06B), while UnitedHealth Group Inc trades at $370.61 (market cap $337.48B). The key difference: UnitedHealth Group Inc is far larger — about 33.5× Modine Manufacturing Company's market cap, and UnitedHealth Group Inc pays a 2.47% dividend while Modine Manufacturing Company pays none. Which is the better fit depends on your goals — on Pluang, investors hold Modine Manufacturing Company for 33 Days and UnitedHealth Group Inc for 97 Days on average.
| MOD | UNH | |
|---|---|---|
Market Cap | $10.06B | $337.48B |
Volume | 1,340,605 | 5,620,541 |
Sector | Industrials | Health |
52-Week High | $283.95 | $436.35 |
52-Week Low | $110.73 | $259.02 |
Typical Hold Time | 33 Days | 97 Days |
Enterprise Value | $10.49B | $379.34B |
Dividend Yield | — | 2.47% |
Signals from Pluang's Aura AI — not financial advice
Modine Manufacturing (MOD) trades at $189.44, down 0.25% on the day, with a neutral technical signal. The stock shows strong fundamental performance, beating earnings estimates for three consecutive quarters, and benefits from a bullish analyst consensus with a $331.25 price target. Recent corporate actions include the completion of a $946 million spin-off of its Performance Technologies unit, potentially streamlining operations for future growth.
The outlook remains positive given earnings momentum and strategic focus on thermal management solutions, but risks include a high P/E ratio of 70.69 and potential integration challenges post-spin-off. Revenue growth to $3.4B in 2026, though with a declining net margin, suggests scaling operations may pressure profitability near-term.
UnitedHealth Group (UNH) trades at $370.95, down 1.43% on the day, with a bullish technical signal and strong analyst support. Recent earnings beats and a raised 2026 outlook highlight fundamental strength, though net income margins have compressed. The stock is supported by a $2.32 dividend payment scheduled for September 22, 2026, and positive sentiment around Medicare Advantage and Optum growth.
The outlook remains positive with an 82.7% analyst buy rating and a $473.89 consensus price target, implying significant upside. Key risks include regulatory pressures and medical cost trends, but strategic AI investments and solid cash flow support long-term growth. Investors should weigh the attractive valuation against execution risks in a dynamic healthcare landscape.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Modine Manufacturing Company is a global leader in thermal management technology and solutions. The company engineers, manufactures, and markets heat transfer products for a wide range of applications across the automotive, commercial, industrial, and HVAC (heating, ventilation, and air conditioning) markets. Modine's products include engine cooling systems, heat exchangers, and ventilation systems, providing critical thermal solutions for vehicles, data centers, and various equipment worldwide.
Read more on MOD →UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →